JAK2 Mutation May Predict Response and Guide First Line Treatment in Rheumatoid Arthritis

Clinical trial NCT04667988 · COMPLETED

Trial details

NCT number: NCT04667988
Sponsor: Mansoura University
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Response Assessment in Newly Diagnosed RA Patients at 3rd Month Was Evaluated by DAS28 and ACR in Relation to JAK Expression

Start date: 2019-01-01
Primary completion: 2020-04-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.